Michael Smolinski, Ph.D.

Senior Vice President of Chemical Development & Pharmaceutical Sciences

Michael joins Nirogy after 14 years at Athenex Inc. where he developed a strong proficiency in drug development with a robust track record of subject matter expertise in CMC, nonclinical, medicinal chemistry, and intellectual property.

During Michael’s tenure at Athenex, he progressed from an entry-level Ph.D. chemist at the then private start-up company with a single clinical product, to Chief Scientific Officer of a publicly-traded company with 500+ employees and a robust product portfolio of 10 products primarily in the oral oncology arena, as well as KlisyriⓇ (tirbanibulin), a topical drug recently approved by FDA/EMA. During this time he served as contributor/lead on CMC and nonclinical subject matter for 9 INDs and 2 New Drug Applications (NDAs) in the US and Marketing Authorization Applications (MAAs) in Europe.

Michael has an established track record of success in research and invention of proprietary drug formulation compositions, processes, methods and uses and advancing them into clinical trials with a keen eye toward bridging science, marketing, medical need, and proprietary positions to identify opportunities for product development.

Michael holds a Ph.D. in Chemistry from the State University of New York at Buffalo and completed post-doctoral training at The Scripps Research Institute in Florida.

Nelly Kuklin, Ph.D.

Scroll to Top

This website uses cookies to ensure you get the best experience on our website.

Vincent P. Sandanayaka, Ph.D.


At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat